Shots: The approval is based on the study assessing Ruzurgi vs PBO in 32 adult patients while patients taking Ruzurgi for at least three months prior to entering the study […]readmore
Tags : Lambert-Eaton Myasthenic Syndrome
Regulatory
Catalyst’s Firdapse (amifampridine) Receives FDA’s Approval for Lambert-Eaton Myasthenic Syndrome
Shots: The approval is based on two clinical trial results assessing Firdapse vs PBO in 64 patients with Lambert-Eaton Myasthenic Syndrome The study measured Quantitative Myasthenia Gravis score (assessing muscle […]readmore